Journal of Hepatology
Volume 27, Issue 4 , Pages 613-619 , October 1997

Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection

  • Len D. Moaven

      Affiliations

    • Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Melbourne, Australia
    • ,
  • Stephen A. Locarnini

      Affiliations

    • Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Melbourne, Australia
    • ,
  • D.Scott Bowden

      Affiliations

    • Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Melbourne, Australia
    • ,
  • Jungsuh P. Kim

      Affiliations

    • Genelabs Technologies, Inc., Redwood City, California, USA
    • ,
  • Alan Breschkin

      Affiliations

    • Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Melbourne, Australia
    • ,
  • Rhonda McCaw

      Affiliations

    • Victorian Infectious Diseases Reference Laboratory, Fairfield Hospital, Melbourne, Australia
    • ,
  • Andersen Yun

      Affiliations

    • Genelabs Technologies, Inc., Redwood City, California, USA
    • ,
  • John Wages Jr

      Affiliations

    • Genelabs Technologies, Inc., Redwood City, California, USA
    • ,
  • Bob Jones

      Affiliations

    • Liver Transplant Unit, Austin Hospital & Repatriation Medical Centre, Melbourne, Australia
    • ,
  • Peter Angus

      Affiliations

    • Corresponding Author InformationCorrespondence: Peter Angus, Liver Transplant Unit, Heidelberg House, Austin Campus, Austin Hospital & Repatriation Medical Centre, Studley Road, Heidelberg, Victoria 3084, Australia. Tel: 61 3 9496 5353. Fax: 61 3 9496 3487.
    • Liver Transplant Unit, Austin Hospital & Repatriation Medical Centre, Melbourne, Australia

Received 15 January 1997 ,Revised 15 April 1997 ,Accepted 9 May 1997.

References 

  1. Wright TL. Etiology of fulminant hepatic failure: is another virus involved?. Gastroenterology. 1993;104:640–653
  2. Alter MJ, Bradley DW. Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC). Semin Liver Dis. 1995;15:110–120
  3. Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al.  Molecular cloning all and disease association of hepatitis G virus: a transfusion-transmissible agent. Science. 1996;271:505–508
  4. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al.  Isolation of novel virus-like sequences associated with human hepatitis. Nature Med. 1995;1:564–569
  5. Zuckerman AJ. Alphabet of hepatitis viruses (editorial). Lancet. 1996;347:558–559
  6. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet. 1995;346:1131–1132
  7. Tameda Y, Kosaka Y, Tagawa S, Takase K, Sawada N, Nakao H, et al.  Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol. 1996;25:842–847
  8. Kao HJ, Chen PJ, Chen DS. GBV-C in the aetiology of fulminant hepatitis. Lancet. 1996;347:120
  9. Mishiro S, Yoshiba M, Okamoto H. GBV-C in the aetiology of fulminant hepatitis. Lancet. 1996;347:120–121
  10. Kuroki T, Nishiguchi S, Tanaka M, Enomoto M, Kobayashi K. Does GBV-C cause fulminant hepatitis in Japan?. Lancet. 1996;347:908
  11. Sallie R, Shaw J, Mutimer D. GBV-C virus and fulminant hepatic failure. Lancet. 1996;347:1552
  12. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Boker K, Muerhoff AS, et al.  Association between fulminant hepatic failure and a strain of GBV virus C. Lancet. 1996;348:1626–1629
  13. Angus PW, Locarnini SA, McCaughan GW, Jones RM, McMillan JS, Bowden DS. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology. 1995;21:14–18
  14. Crofts N, Hopper JL, Bowden DS, Breschkin AM, Milner R, Locarnini SA. Hepatitis C virus infection among a cohort of Victorain injecting drug users. Med J Aust. 1993;159:237–241
  15. Moaven LD, Van Asten M, Crofts N, Locarnini SA. The seroepidemiology of hepatitis E in selected Australian populations. J Med Virol. 1995;45:326–330
  16. Langnas AN, Markin RS, Cattral MS, Naides SJ. Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anaemia. Hepatology. 1995;22:1661–1665
  17. Tang MLK, Kemp AS, Moaven LD. Parvovirus B19-associated red cell aplasia in combined immunodeficiency with normal immunoglobulins. Pediatr Infect Dis J. 1994;13:539–542
  18. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature. 1989;339:237–238
  19. Chemczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem. 1987;167:156–159
  20. Moaven LD, Hyland CA, Young IF, Bowden DS, McCaw R, Mison L, et al.  Pervalence of hepatitis G virus in Queensland blood donors. Med J Aust. 1996;165:369–371
  21. Schlueter V, Schmolke S, Stark K, Hess G, Ofenloch-Haehnle B, Engel AM. Reverse transcription-PCR detection of hepatitis G virus. J Clin Microbiol. 1996;34:2660–2664
  22. Wright TL, Mamish D, Combs C, Kim M, Donegan E, Ferrell L, et al.  Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet. 1992;339:952–955
  23. Tacke M, Kiyosawa K, Stark K, Schlueter V, Ofenloch-Haehnle B, Hess G, et al.  Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet. 1997;349:318–320
  24. Pilot-Matias TJ, Carrick RJ, Coleman PF, Leary TP, Surowy TK, Simons JN, et al.  Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector sysetm and its utility as a serologic marker. Virology. 1996;225:282–292
  25. Berenguer M, Terrault NA, Piatak M, Yun A, Kim JP, Lau JYN, et al.  Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology. 1996;111:1569–1575
  26. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al.  Infection with hepatitis GB virus C in patients on maintenace haemodialysis. N Engl J Med. 1996;334:1485–1490
  27. Alter HJ, Nakatsuji Y, Melpolder J, Kiyosawa K, Wages J, Wesley R, et al.  The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med. 1997;336:741–746

PII: S0168-8278(97)80077-3

Journal of Hepatology
Volume 27, Issue 4 , Pages 613-619 , October 1997

Article Tools